An analysis of polygenic risk scores for non-alcoholic fatty liver disease
- PMID: 34024056
- PMCID: PMC8273633
- DOI: 10.3350/cmh.2021.0133
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Keywords: Genes; Non-alcoholic fatty liver disease; Polymorphism, Single nucleotide.
Conflict of interest statement
Comment on
-
Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort.Clin Mol Hepatol. 2021 Jul;27(3):486-498. doi: 10.3350/cmh.2020.0162. Epub 2021 Feb 23. Clin Mol Hepatol. 2021. PMID: 33618508 Free PMC article.
References
-
- Gellert-Kristensen H, Richardson TG, Davey Smith G, Nordestgaard BG, Tybjaerg-Hansen A, Stender S. Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population. Hepatology. 2020;72:845–856. - PubMed
-
- Koo BK, Joo SK, Kim D, Lee S, Bae JM, Park JH, et al. Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in Asian patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18:2592–2599.e10. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
